Navigation Links
Reportlinker Adds Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
Date:8/31/2010

t Guidance 10

3 Global WH Disorder Therapeutics Market: Market Characterization 11

3.1 Introduction 11

3.2 Revenue Forecasts for the Global WH Disorder Therapeutics Market 12

3.2.1 Sales Value 12

3.2.2 Annual Cost of Therapy 13

3.2.3 Treatment Usage Patterns 14

3.2.4 Generics' Share in the Global WH Disorder Therapeutics Market 20

4 Global WH Disorder Therapeutics Market: Therapeutic Landscape 21

4.1 Global Menopause Therapeutics Market 21

4.1.1 Introduction 21

4.1.2 Sales Value 21

4.1.3 Annual Cost of Therapy 23

4.1.4 Treatment Usage Patterns 24

4.1.5 Drivers and Barriers for the Menopause Therapeutics Market 30

4.1.6 Market share by Geography 31

4.1.7 Product Analysis 33

4.2 Global Endometriosis Therapeutics Market 38

4.2.1 Introduction 38

4.2.2 Sales Value 39

4.2.3 Annual Cost of Therapy 40

4.2.4 Treatment Usage Patterns 41

4.2.5 Drivers and Barriers for the Endometriosis Therapeutics Market 46

4.2.6 Market share by Geography 47

4.2.7 Product Analysis 48

4.3 Global Postmenopausal Osteoporosis (PMO) Market 51

4.3.1 Introduction 51

4.3.2 Sales Value 52

4.3.3 Annual Cost of Therapy 53

4.3.4 Treatment Usage Patterns 54

4.3.5 Drivers and Barriers for the Menopause Therapeutics Market 60

4.3.6 Market Share by Geography 61

4.3.7 Product Analysis 63

5 Global WH Disorder Therapeutics Market: Geographical Landscape 68

5.1 Geographical Break-up 68

5.2 The US 71

5.2.1 Sales Value 71

5.2.2 Annual Cost of Therapy 72

5.2.3 Treatment Usage Patterns 73

5.3 Top Five Markets in Europe 78

5.3.1 Sales Value 78

5.3.2 Annual Cost of Therapy 79

5.3.3 Treatment Usage Patterns 80

5.4 Japan 85

5.4.1 Sales Value 85

5.4.2 Annual Cost of Therapy 86

5.4.3 Treatment Usage Patter
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
2. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
3. Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?
4. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
5. Reportlinker Adds Advances in Biopharmaceutical Technology in China
6. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
7. Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016
8. Reportlinker Adds Stem Cells Market And Applications. 2009-2015
9. Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential
10. Reportlinker Adds Global Nucleic Acid Testing Industry
11. Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... SEATTLE , June 2, 2015 TapImmune, ... and its institutional investors have reached an agreement whereby ... their short term warrants to provide the Company up ... and an effective S-1 registration statement. Under the restructured ... may also call additional warrants which could result in ...
(Date:6/2/2015)... 2, 2015 /CNW/ - Shell today celebrated the North American ... category with an exhibit the size of a city ... demonstrations for media and the public, and special appearances ... Premium Gasoline provides the best total engine protection by ... wear, gunk and corrosion. "With the launch ...
(Date:6/2/2015)... and TORONTO , June 2, ... TSX: APS), a clinical-stage company developing new therapeutics that ... the U.S. Food and Drug Administration (FDA) has granted ... treatment of acute myeloid leukemia (AML). APTO-253, a first-in-class ... product candidate in a Phase Ib clinical trial in ...
(Date:6/2/2015)... Global Stem Cells Group subsidiary Adimarket has been ... for the regeneration and repair of human organs and tissues. ... ambitious expansion plans in Latin America, a commitment made to ... and stem cell therapies. , Bioquark Inc. ... ability to alter the regulatory state of human tissues and ...
Breaking Biology Technology:TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 2TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 4Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 3
... Live On Company,s Website -, TUSTIN, Calif., Oct. ... clinical stage biopharmaceutical,company developing monoclonal antibodies for the treatment ... management will,present at the BIO Investor Forum 2008 on ... EDT). The conference will be held at the Palace ...
... 28 Neurocrine Biosciences,(Nasdaq: NBIX ) announces the following Webcast:, ... When: October 28, 2008 @ 5 p.m. Eastern ... How: Live over the Internet -- Simply log ... above., Contact: Claudia Woodworth, 858-617-7759 ...
... MEMY ) today announced that it has received,notice ... of the,Company,s common stock will be transferred from The ... the opening of trading on October,28, 2008. The Company,s ... The Panel has also notified the Company that it ...
Cached Biology Technology:Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2Memory Pharmaceuticals Provides Update on NASDAQ Listing Status 2Memory Pharmaceuticals Provides Update on NASDAQ Listing Status 3
(Date:6/1/2015)... According to a new market research report ... & Touchless), Application (Consumer Electronics, Automotive, & Others), Product ... Forecast to 2020", published by MarketsandMarkets, the Gesture Recognition ... Billion by 2020, at a CAGR of 28.23% between ... data T ables and   86   F ...
(Date:6/1/2015)... 1, 2015 According to ... Market by Application (Government, Military & Defense, Healthcare, ... and Security), Technology (Face Recognition, Fingerprint Recognition, Iris ... Recognition, and Others), Function (Contact and Non-Contact) & ... Europe , APAC, Row) - Global ...
(Date:5/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ... "Facial Recognition Market by Solution, by Software, by ... 2020" report to their offering. ... technology become more efficient and cost effective. This ... investment from the commercial sector. The development of ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... with a common condition that causes frequent nighttime ... minimally invasive treatment that shrinks the prostate, suggests a ... 38th Annual Scientific Meeting in New Orleans. The early ... prostatic artery embolization (PAE), which reduces blood flow to ...
... Inc. (OTC Markets: MDBX) ( www.medboxinc.com ), a leader ... to various medical and retail related industries worldwide, seeks ... in the mushrooming legal marijuana industry and has issued a ... past, present, and future projects. Company CEO, ...
... sea levels, new research indicates that cutting emissions of ... this century. The research team found that reductions ... atmosphere could temporarily forestall the rate of sea level ... avoid potentially dangerous sea level rise, we could cut ...
Cached Biology News:Nonsurgical treatment turns back the clock, shrinks enlarged prostate 2Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 2Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 3Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 4Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 5Cutting specific pollutants would slow sea level rise 2Cutting specific pollutants would slow sea level rise 3
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
...
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Biology Products: